INTRODUCTIONRosacea is a common inflammatory skin disorder estimated to affect 16 million Americans.1 Although it is usually observed in patients with light skin phototype, rosacea has also been diagnosed in…

BACKGROUND Photodynamic therapy (PDT) has become an established option in the management of actinic keratoses (AKs) and other skin diseases. Cutaneous PDT has predominantly involved the use of methyl aminolevulinate…

INTRODUCTIONFacial appearance is a defining hallmark of identity and self-confidence.1, 2 Changes in skin quality, such as the loss of elasticity and decreased dermal thickness, in addition to alterations in…

INTRODUCTION Patients with traumatic scarring often seek both aesthetic and functional improvement and can be a challenge to treat; however, advances in laser and light technologies have helped to treat…

The combined use of topical delivery and dermalinfusion® of decapeptide-12 represents a novel, safe, and efficacious noninvasive approach to achieve accelerated resolution of postinflammatory hyperpigmentation (PIH), an especially difficult to…

Dermatology at Washington University The tradition of Dermatology at Washington University School of Medicine can be best traced back to the earliest history of the Siteman Cancer Center in the…

ACKNOWLDEGMENTDr. L. Brodell wrote the first draft of this manuscript. Dr. M. Anadkat MD reviewed and approved the content of the final draft. This case has not been previously published…

INTRODUCTION Flagellate erythema has been associated with eating raw or undercooked shitake mushrooms (Lentinus edodes), in association with autoimmune diseases such as dermatomyositis,lupus erythematosus, or Still’s Disease, and following bleomycin…

In the outpatient setting, skin and soft tissue infections of all types, including community-acquired methicillin-resistant staphylococcus aureus (MRSA), remain common. While the nares is the most common site of colonization,…

FDA Approves Anti-Fungal Luzu Valeant Pharmaceuticals North America LLC, has received notice that the New Drug Application for Luzu® (luliconazole) Cream, 1% has been approved by the FDA. Luzu® Cream,…

An Open Label Study Employing the Topical Immunomodulator Diphenylcyclopropenone in a Stabilized Gel to Treat Cutaneous MetastasesSponsored by Rockefeller University, this is an open label study to determine the efficacy…